Black Rock Inc. Evotec Se Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Evotec Se stock. As of the latest transaction made, Black Rock Inc. holds 82,598 shares of EVO stock, worth $366,735. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,598
Previous 37,600
119.68%
Holding current value
$366,735
Previous $294,000
34.69%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding EVO
# of Institutions
26Shares Held
2.91MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA2.3MShares$10.2 Million0.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT230KShares$1.02 Million0.54% of portfolio
-
Morgan Stanley New York, NY126KShares$559,0890.0% of portfolio
-
Goldman Sachs Group Inc New York, NY61.1KShares$271,3630.0% of portfolio
-
Lighthouse Investment Partners, LLC Palm Beach Gardens, FL39.8KShares$176,7250.01% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.57B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...